STEVEN HAMBURGER, Ph.D.
VICE PRESIDENT, REGULATORY AFFAIRS & QUALITY ASSURANCE
Steven Hamburger, Ph.D. is Vice President, Regulatory Affairs & Quality Assurance at Tarveda. Prior to joining Tarveda, Dr. Hamburger served as Vice President, Regulatory Affairs and Quality Assurance at Berg where he provided global regulatory and quality strategic guidance and input with a focus on oncology and rare diseases. He has led global regulatory efforts for both biotech and large pharmaceutical companies including Castle Creek Pharmaceuticals, Baxalta and Immunomedics. Dr. Hamburger has also held senior regulatory positions at Millennium/Takeda, Johnson & Johnson, Eli Lilly, and Zeneca Pharmaceuticals. He has had significant involvement in the development and/or global registration of many drugs including Krystexxa, Onivyde, Oncaspar, Velcade, Alimta, DOXIL and Accolate. Dr. Hamburger holds a Ph.D. in pharmacology and toxicology from Indiana University School of Medicine, an M.S. from Butler University and a B.S. from the University of Iowa.